Introduction: Bladder cancer represents 7% of all new cancers diagnosed in the USA in
2015. Furthermore, the mortality of metastatic bladder cancer has not decreased …

Purpose: Based on a large-population analysis, we aimed to estimate the incidence and
survival of bone metastases (BM) in initial bladder cancer (BC) patients and to identify the …

Objective Our objective was to investigate age-and sex-related differences in the distribution
of metastases in patients with metastatic bladder cancer. Methods Within the National …

Background To explore the overall trends of incidence rate (IR), mortality and survival
outcomes of patients with urothelial bladder cancer (UBC) over the past two decades …

Purpose Growing evidence has demonstrated an indispensable role for N6‐
methyladenosine (m6A) in human diseases, but the copy number variations (CNVs) of m6A …

Bladder cancer (BC) ranks as the ninth common human tumor in the world with an
increasing incidence. Circular RNAs (circRNAs) have been revealed to exhibit promotive or …

Systemic therapy for urothelial carcinoma (UC) of the bladder has largely revolved around
cytotoxic chemotherapy regimens. However, several recent clinical trials have explored the …

Simple Summary The role of circular RNAs has made breakthroughs in understanding the
mechanisms of tumor development. Bladder cancer has an increasing incidence, high …

Background The mutational pattern of homologous recombination repair (HRR)‐associated
gene alterations in Chinese urothelial carcinoma (UC) necessitates comprehensive …

Bladder cancer is a common type of cancer with an estimated incidence of more than 70,000
patients and had a mortality of 16,000 patients in the US in 2015. In more than 70% of cases …